Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMVACS: integrating malaria vaccination with seasonal malaria chemoprevention in West Africa
PACTR202502765006598Phase 4Not yet recruiting
- Sponsor
- Illumina
- Start
- Apr 2025
- Countries
- 2
01
Overview
Phase 4, open-label trial in malaria (2 arms), sponsored by Illumina. Primary endpoint: Malaria incidence. Planned start Apr 2025; status: not yet recruiting.
02
Conditions
malaria
Beyond the preview
Go deeper on PACTR202502765006598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502765006598.